mRNA |
GSK269962A |
GDSC1000 |
pan-cancer |
AAC |
-0.079 |
0.02 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.084 |
0.02 |
mRNA |
PIK-93 |
GDSC1000 |
pan-cancer |
AAC |
0.067 |
0.02 |
mRNA |
CHIR-99021 |
CTRPv2 |
pan-cancer |
AAC |
-0.074 |
0.02 |
mRNA |
JQ-1:MK-0752 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.074 |
0.02 |
mRNA |
CHIR-99021 |
GDSC1000 |
pan-cancer |
AAC |
-0.073 |
0.02 |
mRNA |
Nilotinib |
GDSC1000 |
pan-cancer |
AAC |
-0.083 |
0.02 |
mRNA |
Vandetanib |
CCLE |
pan-cancer |
AAC |
-0.1 |
0.03 |
mRNA |
AZD0530 |
CCLE |
pan-cancer |
AAC |
-0.1 |
0.03 |
mRNA |
sotrastaurin |
CTRPv2 |
pan-cancer |
AAC |
0.085 |
0.03 |